chr15-78629237-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_000750.5(CHRNB4):c.1068G>A(p.Pro356Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000392 in 1,613,392 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 3 hom. )
Consequence
CHRNB4
NM_000750.5 synonymous
NM_000750.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.515
Genes affected
CHRNB4 (HGNC:1964): (cholinergic receptor nicotinic beta 4 subunit) This gene is found within a conserved gene cluster and encodes one of the beta subunits of the nicotinic acetylcholine receptor (nAChRs) superfamily which form ligand-gated ion channels with a central pore that forms a cation channel. Neuronal nAChRs are pentameric structures that can be either homomeric or heteromeric, with heteromeric structures containing both alpha and beta subunits. Each subunit contains an extracellular amino terminus and four transmembrane domains. Nicotine is one of the agonists that binds to the receptor. Variants in this gene have been associated with nicotine dependence and lung cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 15-78629237-C-T is Benign according to our data. Variant chr15-78629237-C-T is described in ClinVar as [Benign]. Clinvar id is 718587.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.515 with no splicing effect.
BS2
High AC in GnomAd4 at 307 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNB4 | ENST00000261751.8 | c.1068G>A | p.Pro356Pro | synonymous_variant | Exon 5 of 6 | 1 | NM_000750.5 | ENSP00000261751.3 | ||
CHRNB4 | ENST00000412074.6 | c.359+1839G>A | intron_variant | Intron 4 of 4 | 1 | ENSP00000416386.2 | ||||
ENSG00000259555 | ENST00000821537.1 | n.312+1672C>T | intron_variant | Intron 2 of 2 | ||||||
CHRNB4 | ENST00000559849.5 | n.*1124G>A | downstream_gene_variant | 1 | ENSP00000457404.1 |
Frequencies
GnomAD3 genomes AF: 0.00202 AC: 307AN: 152088Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
307
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000562 AC: 141AN: 250678 AF XY: 0.000406 show subpopulations
GnomAD2 exomes
AF:
AC:
141
AN:
250678
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000222 AC: 325AN: 1461186Hom.: 3 Cov.: 31 AF XY: 0.000193 AC XY: 140AN XY: 726772 show subpopulations
GnomAD4 exome
AF:
AC:
325
AN:
1461186
Hom.:
Cov.:
31
AF XY:
AC XY:
140
AN XY:
726772
show subpopulations
African (AFR)
AF:
AC:
259
AN:
33476
American (AMR)
AF:
AC:
16
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26114
East Asian (EAS)
AF:
AC:
0
AN:
39688
South Asian (SAS)
AF:
AC:
7
AN:
86228
European-Finnish (FIN)
AF:
AC:
0
AN:
53264
Middle Eastern (MID)
AF:
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
6
AN:
1111578
Other (OTH)
AF:
AC:
37
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
25
50
76
101
126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00202 AC: 307AN: 152206Hom.: 1 Cov.: 32 AF XY: 0.00185 AC XY: 138AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
307
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
138
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
296
AN:
41546
American (AMR)
AF:
AC:
10
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5164
South Asian (SAS)
AF:
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68010
Other (OTH)
AF:
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jan 30, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
Loading publications...